CYPLOX

This brand name is authorized in Nigeria. It is also authorized in Hong Kong SAR China.

Active ingredients

The drug CYPLOX contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-3202	Tablet	Cyplox 500mg Tablet TAB 500 mg	CYPLOX 500MG TABLET 04-3202 CYPLOX 500MG TABLET CIPROFLOXACIN 500MG Prescription Only Medicine (POM) SANOFI-AVENTIS NIGERIA LIMITED, JAPAUL HOUSE, DR.NURUDEEN OLOWOPOPO AVENUE IKEJA LAGOS MEDREICH LIMITED, INDIA, SURVEY NO. 4/3, AVALAHALLI, ANJANAPURA POST, OFF KANAKAPURA ROAD, BANGALORE 560 062, INDIA, India 23/02/2023 22/02/2028	23/02/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	55718
NG	Registered Drug Product Database	04-3202